Cite

HARVARD Citation

    van Hall, V. et al. (n.d.). P23 Assessing the Long-term Outcomes of Ocrelizumab Treatment in Germany – CONFIDENCE Baseline Characteristics. Clinical neurophysiology. 131 (4), pp. e187-e188. [Online]. 
  
Back to record